Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

The Trump administration finalized new rules to make healthcare price transparency data more accessible and accurate. Key changes include quarterly (instead of monthly) reporting, personalized pricing by phone, and C-suite accountability for data accuracy. The FTC is also stepping up enforcement against hospitals that fall short on compliance.
The Centers for Medicare & Medicaid Services (CMS) has finalized a rule aimed at making healthcare price transparency data far more usable for patients, employers, and innovators. While payers and providers have been required to publish negotiated pricing data for years, those files have been notoriously massive, hard to find, and riddled with errors — making them more of a compliance checkbox than a practical tool.
The updated rule tackles those pain points head-on. Reporting frequency shifts from monthly to quarterly to reduce administrative burden, while data quality standards are raised significantly. Insurers must now offer personalized pricing information to members by phone — not just online — and C-level executives at health plans will be required to personally attest to the accuracy of submitted data. CMS Administrator Dr. Mehmet Oz framed the changes as a catalyst for a new wave of price comparison tools and AI-powered applications that could help patients and employers make smarter healthcare spending decisions.
Key Takeaways:
Why it matters: Healthcare pricing has long been a black box. These reforms could meaningfully shift power toward patients and employers — and spark a new generation of tools that make cost comparisons far more straightforward.